AI assistant
Sending…
Medpace Holdings, Inc. — Director's Dealing 2021
Dec 7, 2021
30442_dirs_2021-12-07_5f7b1bbc-0fc0-4430-bfdc-e6b72295af79.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-12-03
Reporting Person: Medpace Investors, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-03 | Common Stock | S | 400 | $211.48 | Disposed | 5807924 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.25 to $211.92. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
More from Medpace Holdings, Inc.
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 22
Annual Report
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 17